[Rifampicin, a new antitubercular bactericide].
D000818:Animals; D000995:Antitubercular Agents; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D051379:Mice; D011247:Pregnancy; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology
D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin
La rifampicine, nouveau bactéricide anti-tuberculeux.